Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer

BACKGROUND: High serum phosphate and fibroblast growth factor-23 (FGF-23) levels are well-recognized independent risk factors of mortality and morbidity in patients with chronic kidney diseases (CKDs). Sevelamer, as a phosphate chelating agent, reduces serum phosphate and FGF-23 levels produced by b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Bone Metab
Egile Nagusiak: Ghorbanihaghjo, Amir, Argani, Hassan, Golmohamadi, Zahra, Rashtchizadeh, Nadereh, Abbasi, Mehran Mesgari, Bargahi, Nasrin, Vatankhah, Amir Mansour, Sanajou, Davoud
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society for Bone and Mineral Research 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135647/
https://ncbi.nlm.nih.gov/pubmed/30237994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2018.25.3.153
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak